The prognostic role of high-sensitivity C-reactive protein in patients with acute myocardial infarction
Ekaterina A Polyakova1
Evgeny N Mikhaylov2
1.Department of Faculty Therapy, Pavlov First Saint-Petersburg State Medical University, Saint-Petersburg, Russian Federation;Metabolic Syndrome Laboratory, Institute of Endocrinology, Almazov National Medical Research Centre, Saint-Petersburg, Russian Federation2.Neuromodulation Lab and Arrhythmia Department, Almazov National Medical Research Centre, Saint Petersburg, Russian Federation;Department of Bioengineering Systems, Saint-Petersburg Electrotechnical University "LETI", Saint Petersburg, Russian Federation
摘要：1 Introduction
Inflammation is one of the main mechanisms in the pathogenesis of atherosclerosis, and the interest to the evaluation of inflammatory biomarkers in coronary artery disease (CAD) has been increasing over the last decade.[1,2]Destabilization of chronic artery plaques, which leads to acute coronary syndromes, has been associated with inflammatory status.[1,3]
C-reactive protein (CRP) is a plasma protein of the pentraxins family.CRP is widely used as a general inflammatory marker since it is an acute phase protein synthesized by hepatocytes in response to proinflammatory cytokines,particularly interleukin-6.
机标关键词：
论文发表日期：2020-07-28
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：5( 379-383 )
英文信息